Report for Top 100 2021 - Old School Mix

Report overview

Total mentions

1,894,399

Total number of mentions for research outputs in this report

Research outputs

100

Total number of research outputs in this report, including those without mentions

Outputs with mentions

100

Total number of research outputs in this report that have Altmetric mentions

Sources of attention

Number of attention sources that mention research outputs in this report

Attention source breakdown

The number of mentions from each source that Altmetric has tracked for the research outputs in this report.

News mentions

54,974

Blog mentions

3,065

Policy mentions

2,187

Patent mentions

765

X mentions

1,776,618

Peer review mentions

Facebook mentions

1,736

Wikipedia mentions

686

Reddit mentions

50,262

Faculty Opinions mentions

Q&A mentions

YouTube mentions

557

Clinical guidelines

238

Bluesky mentions

2,541

Podcast mentions

639

Attention over time

This chart shows all mentions for research outputs in your report.

Top 20 research outputs

Below is a list of the top 20 research outputs in this report. Each research output has an Altmetric Attention Score , which provides an indicator of the amount of attention that has been received.

Rank	Attention Score	Research output
#1		Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine Article in New England Journal of Medicine, December 2020
#2		Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers Article in Annals of Internal Medicine, November 2020
#3		Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia Article in The Lancet, February 2021
#4		Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States Article in European Journal of Epidemiology, September 2021
#5		Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China Article in Nature Communications, November 2020
#6		Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons Article in New England Journal of Medicine, April 2021
#7		Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021 Article in MMWR: Morbidity & Mortality Weekly Report, August 2021
#8		Ten scientific reasons in support of airborne transmission of SARS-CoV-2 Article in The Lancet, April 2021
#9		Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19 Article in New Microbes and New Infections, August 2021
#10		Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease Article in International journal of clinical practice, December 2020
#11		COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room Article in The Lancet Microbe, April 2021
#12		Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19 Article in European Journal of Clinical Investigation, February 2021
#13		Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant Article in New England Journal of Medicine, July 2021
#14		Airborne transmission of respiratory viruses Article in Science, August 2021
#15		BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting Article in New England Journal of Medicine, February 2021
#16		An mRNA Vaccine against SARS-CoV-2 — Preliminary Report Article in New England Journal of Medicine, July 2020
#17		Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting Article in New England Journal of Medicine, August 2021
#18		Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021 Article in MMWR: Morbidity & Mortality Weekly Report, November 2021
#19		Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Article in The Lancet, December 2020
#20		Remdesivir for the Treatment of Covid-19 — Final Report Article in New England Journal of Medicine, October 2020

The information in this report was last updated at 00:00AM UTC on 2026-10-15.

This report was produced by the Altmetric Explorer. For more information about Altmetric, visit www.altmetric.com.

Report for Top 100 2021 - Old School Mix

Report overview

Attention source breakdown

Attention over time

Top 20 research outputs

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States

Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021

Ten scientific reasons in support of airborne transmission of SARS-CoV-2

Ivermectin: a multifaceted drug of Nobel prize-honoured distinction with indicated efficacy against a new global scourge, COVID-19

Informed consent disclosure to vaccine trial subjects of risk of COVID‐19 vaccines worsening clinical disease

COVID-19 vaccine efficacy and effectiveness—the elephant (not) in the room

Assessing mandatory stay‐at‐home and business closure effects on the spread of COVID‐19

Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

Airborne transmission of respiratory viruses

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting

Laboratory-Confirmed COVID-19 Among Adults Hospitalized with COVID-19–Like Illness with Infection-Induced or mRNA Vaccine-Induced SARS-CoV-2 Immunity — Nine States, January–September 2021

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Remdesivir for the Treatment of Covid-19 — Final Report